![PIQRAY (alpelisib)tablets 300 mg, 28 Tablets at Rs 15000/box | Alpelisib Tablet in Mumbai | ID: 2853152254612 PIQRAY (alpelisib)tablets 300 mg, 28 Tablets at Rs 15000/box | Alpelisib Tablet in Mumbai | ID: 2853152254612](http://5.imimg.com/data5/SELLER/Default/2023/12/372788784/ZW/UE/NV/204033797/piqray-alpelisib-tablets-300-mg-500x500.jpg)
PIQRAY (alpelisib)tablets 300 mg, 28 Tablets at Rs 15000/box | Alpelisib Tablet in Mumbai | ID: 2853152254612
FDA approves Novartis Piqray® - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer
![PIQRAY (alpelisib) Tablets | Price & Cost | Pharma Network Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA PIQRAY (alpelisib) Tablets | Price & Cost | Pharma Network Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA](https://medvitaz.com/wp-content/uploads/2020/12/piqray.jpg)
PIQRAY (alpelisib) Tablets | Price & Cost | Pharma Network Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA
![Piqray remains a novel treatment option for patients metastatic breast cancer - Drug Discovery and Development Piqray remains a novel treatment option for patients metastatic breast cancer - Drug Discovery and Development](https://www.drugdiscoverytrends.com/wp-content/uploads/2021/07/piqray_dosing_logo_r_rgb_500px.png)
Piqray remains a novel treatment option for patients metastatic breast cancer - Drug Discovery and Development
![Breast cancer precision medicine! Novartis PI3K inhibitor Piqray received EU approval: the first PIK3CA mutation HR+/HER2- breast cancer therapy! - Knowledge - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd Breast cancer precision medicine! Novartis PI3K inhibitor Piqray received EU approval: the first PIK3CA mutation HR+/HER2- breast cancer therapy! - Knowledge - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd](https://www.hsppharma.com/Content/uploads/2020524038/20200806093612ae34e95bd63246fda578934397f34940.png)
Breast cancer precision medicine! Novartis PI3K inhibitor Piqray received EU approval: the first PIK3CA mutation HR+/HER2- breast cancer therapy! - Knowledge - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd
![Piqray Alpelisib 300 mg Tablets at Rs 154000/box | Alpelisib Tablet in Chandigarh | ID: 2852878688412 Piqray Alpelisib 300 mg Tablets at Rs 154000/box | Alpelisib Tablet in Chandigarh | ID: 2852878688412](http://5.imimg.com/data5/SELLER/Default/2023/10/356092207/AT/RY/GF/201574836/piqray-alpelisib-tablets-500x500.jpeg)